Pharmaceutical giant Eli Lilly has made a significant shift in its pricing strategy for the popular weight-loss drug Zepbound. The company announced that selected doses would be available at a lower price to help patients without adequate health insurance while strengthening its market position. This move comes at a time when regulatory authorities have declared the end of the drug shortage, and Eli Lilly faces growing competition. Additionally, the company is investing heavily in developing an oral alternative, which could significantly reshape the market.
Recent financial results from Mercedes-Benz reveal that the company faced a harsh wake-up call last year, as it struggled with the slowing shift to electric vehicles and weakening demand in China, once an inexhaustible source of profits for German automakers. Its challenges reflect the tough period during which European vehicle manufacturers are grappling with sharp declines in sales, especially in the electric vehicle sector. However, early sales data for this year suggests improvement, which could be the first sign of market recovery.
CVS Health, one of the largest healthcare companies in the U.S., surprised investors with positive results for the fourth quarter of 2024. Despite challenges, it managed to exceed expectations and demonstrated stable growth in key segments. The company also presented ambitious plans for 2025, which include cost reduction and strategic improvements in Medicare Advantage insurance.
The Coca-Cola Company, a global leader in non-alcoholic beverages, known especially for its Coca-Cola brand, has reported its fourth-quarter financial results for 2024. These results not only surpassed Wall Street expectations but also confirmed steady demand growth for the company’s products despite challenging macroeconomic conditions.
Apple is trying to regain its lost ground in the Chinese market, where competition from homegrown brands like Huawei is nipping at its heels. The latest move is a collaboration with tech e-commerce giant, Alibaba, that will allow it to bring artificial intelligence (AI) services to Chinese users. This strategic move could improve the user experience, but the question remains whether this initiative will be enough to stem the decline in iPhone sales in the region.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 81.75% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
English
Slovak
Czech
Hungarian
Italiano
Polish
